Articles

The TGA has released the findings of its review into breast implants and breast tissue expanders

International Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab

Infringement notice issued for the alleged advertising of Schedule 4 substances

Infringement notice issued for the alleged advertising of a cancelled therapeutic good

New requirements for caffeine and caffeine-containing ingredients within listed medicines

An amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.

Update on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval

The TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices

Direction Notice issued to cease advertising of therapeutic goods not entered in the ARTG

Direction Notice issued to cease advertising of unregistered therapeutic goods to consumers

An individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China

Infringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products

Information on how supplements are regulated in Australia

Improvements to Consumer Medicine Information

Important information about the dangers of using thermography for breast cancer detection

The Federal Court has imposed substantial penalties on Peptide Clinics Australia

Risks associated with cosmetic injections can be related to both the product and the experience of the person performing the procedure

The TGA has clarified that state and territory governments will continue to regulate fluoridated drinking water in Australia

The TGA is urging Australians to return unused prescription pain relief medicines to their local pharmacy

The 2019 TGA stakeholder survey is open. Have your say before 5 July

We're encouraging all Australians to return their unused opioids to their local pharmacy

International work-sharing initiative approves Niraparib (Zejula®)

The Therapeutic Goods (Permissible Ingredients) Determination has been updated.

Reasons for releasing guidance and how it was developed

On Thursday 30 May 2019, the Therapeutic Goods Administration (TGA) executed four search warrants connected to a business operating in the Sutherland Shire, Sydney